Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Debt (2018 - 2025)

Dna X's Non-Current Debt history spans 6 years, with the latest figure at $250000.0 for Q3 2025.

  • Quarterly results put Non-Current Debt at $250000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $250000.0 (changed N/A YoY), and the annual figure for FY2021 was $66000.0, down 64.32%.
  • Non-Current Debt for Q3 2025 was $250000.0 at Dna X, down from $566000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $566000.0 in Q1 2025 to a low of $30000.0 in Q1 2022.
  • The 3-year median for Non-Current Debt is $92500.0 (2021), against an average of $160250.0.
  • Peak annual rise in Non-Current Debt hit 50.0% in 2022, while the deepest fall reached 79.73% in 2022.
  • Year by year, Non-Current Debt stood at $66000.0 in 2021, then plummeted by 43.94% to $37000.0 in 2022, then soared by 575.68% to $250000.0 in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $250000.0, $566000.0, and $37000.0 for Q3 2025, Q1 2025, and Q3 2022 respectively.